Original Publication Date: 27 January, 2014
Publication / Source: Future Oncology
Authors: Timur H Kuru, Matthias Roethke, Michael Fenchel & Boris A Hadaschik
The treatment of pediatric rhabdomyosarcoma (RMS) of the pelvis has been changing in recent years. Local treatment after chemotherapy is delayed or even avoided completely without effecting overall survival. Imaging is playing a growing role in individualized treatment planning in these patients. In cases of questionable recurrence or residual disease, fusion biopsies may allow a safe and reliable bioptic examination.